Table 4.
Relationship between LMR and clinicopathological features in patients with ovarian cancer.
| Charateristics | LMR<3.39 (N=598) | LMR≥3.39 (N=393) | P value |
|---|---|---|---|
| Age[median (range),years] | 54 (35-81) | 56 (23-83) | 0.052 |
| ≤55 | 328 | 193 | 0.077 |
| >55 | 270 | 200 | |
| Menopause | |||
| Yes | 339 | 242 | 0.126 |
| No | 259 | 151 | |
| FIGO stage | |||
| I | 20 | 35 | <0.001 |
| II | 40 | 44 | |
| III | 430 | 252 | |
| IV | 108 | 62 | |
| Family history of cancer | |||
| Yes | 209 | 118 | 0.107 |
| No | 389 | 275 | |
| Residual disease | |||
| ≤1cm | 509 | 350 | 0.074 |
| >1cm | 89 | 43 | |
| Histology | |||
| Serous | 513 | 316 | 0.025 |
| Other | 85 | 77 | |
| Grade | |||
| Well | 214 | 162 | 0.133 |
| Moderate | 148 | 85 | |
| Poor | 175 | 100 | |
| Lymph node status | |||
| Positive | 350 | 198 | 0.012 |
| Negative | 248 | 195 | |
| CA125 at diagnosis | 1181.30 (386.90-2409.68) | 571.75 (159.60-1381.98) | <0.001 |
| ≤35 U/ml | 26 | 25 | 0.160 |
| >35 U/ml | 572 | 368 | |
| Platelet (109/L) | 283.00 (211.00-370.75) | 242.50 (196.75-315.00) | <0.001 |
| Neutrophil (109/L) | 4.90 (3.63-6.38) | 3.80 (2.80-4.73) | <0.001 |
| Lymphocyte (109/L) | 1.30 (1.00-1.50) | 1.70 (1.40-2.03) | <0.001 |
| Monocyte (109/L) | 0.60 (0.40-0.70) | 0.40 (0.30-0.50) | <0.001 |
| NLR | 3.83 (2.83-5.63) | 2.22 (1.60-2.84) | <0.001 |
| LMR | 2.33 (1.75-2.80) | 4.50 (4.00-5.50) | <0.001 |
| PLR | 233.06 (161.57-336.75) | 143.01 (108.25-185.35) | <0.001 |
| SII | 1106.41 (680.39-1873.56) | 530.29 (343.00-782.12) | <0.001 |
| PNR | 49.20 (32.14-71.23) | 38.60 (27.99-55.27) | <0.001 |
The bold values represent P<0.05.